About

RepliCel Life Sciences Inc. (TSXV: RP) is a regenerative medicine company focused on developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function such as chronic tendinosis, damaged skin and male pattern baldness.

RepliCel Life Sciences Inc. (RP.V)
Last Traded
3:59pm - 1.00
Volume
306,012
Open
0.85
Previous Close
0.83
Bid
0.98
Ask
1.02
Bid Size
N/A
Ask Size
N/A
Market Cap
14.93M
Shares Owned
N/A
Peg Ratio
0.00
Dividend Yield
N/A
Events & Conferences